Hair transplants are now being carried out in the US, but many patients do not receive a transplant in time. The problem, in a nutshell, is that the transplant requires a lot of blood, and the risk of complications from the transfusion is high. There is now a new treatment for this. A team of researchers in the UK has discovered a way to safely use blood from a patient's own bone marrow.The r...
BIKRAM has announced the launch of the first derma hair replacement program in Australia, to treat severely-affected patients.
Derma Hair Replacements is the brainchild of Derma-Facial Plastic Surgery (DFPS) CEO Dr Paul O’Neill, who hopes to help people in his home state of New South Wales.
Dermal hair transplant surgery is a major medical and cosmetic procedure that has the potential to be a game-changer in treating the serious cases of skin cancer.
Dermatologists have been using the procedure to treat skin cancer since the 1940s, but Derma has managed to revolutionise the treatment of the disease by introducing a new, less invasive method of treating the disease.
Dermagenics Dermatosurgery Dermatoresurgical surgeons use a laser, scalpel and a surgical tool to remove a layer of skin.
It involves removing a layer that’s been infected with a virus, known as a melanoma.
A surgeon then injects a chemical solution that kills the melanoma cells.
The cancer is removed by removing the infected skin, and the skin grafts back together to the original skin.
The process is often referred to as dermagenesis, and Dr O’Neil says it has a very long-term impact.
“Derma surgery is one of the most important and efficient ways of removing skin cancers,” Dr O ‘Neill said.
“This is why Derma are so proud to be the first to implement dermal hair transplanted surgery in Australia.”
“We are so confident that Derma can deliver this technology that can improve quality of life for patients in our state, and in future generations.”
Dr O, who is a member of the Dermatology Board of Australia, said he and his team had been working on the idea for a long time.
“We have been in discussions with Derma for some time,” he said.